Impact of T-cell Engagers on COVID-19-related Mortality in B-cell Lymphoma Patients Receiving B-cell Depleting Therapy.

Chan Mi Lee,Pyoeng Gyun Choe,Chang Kyung Kang,Hyeon Jae Jo,Nam Joong Kim,Sung-Soo Yoon,Tae Min Kim,Wan Beom Park,Myoung-Don Oh

Cancer research and treatment（2023）

引用 0|浏览11

暂无评分

摘要

B-cell lymphoma patients treated with TCE had significantly worse outcomes from COVID-19 than those treated with RTX. TCE therapy should be used with caution in B-cell lymphoma patients during the COVID-19 epidemic.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要